dazoxiben has been researched along with isbogrel in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashida, S; Ishikawa, F; Kanao, M; Kanaya, N; Kanno, H; Kimura, Y; Kubo, H; Saegusa, J; Watanabe, Y; Yamamoto, K | 1 |
| Ackerley, N; Brewster, AG; Brown, GR; Clarke, DS; Foubister, AJ; Griffin, SJ; Hudson, JA; Smithers, MJ; Whittamore, PR | 1 |
| Lumley, P; Watts, IS; Wharton, KA; White, BP | 1 |
3 other study(ies) available for dazoxiben and isbogrel
| Article | Year |
|---|---|
Thromboxane A2 synthetase inhibitors. 2. Syntheses and activities of tetrahydronaphthalene and indan derivatives.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Platelets; Chemical Phenomena; Chemistry; Dinoprostone; Indans; Indenes; Molecular Structure; Naphthalenes; Rats; Structure-Activity Relationship; Tetrahydronaphthalenes; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase | 1989 |
A novel approach to dual-acting thromboxane receptor antagonist/synthase inhibitors based on the link of 1,3-dioxane-thromboxane receptor antagonists and -thromboxane synthase inhibitors.
Topics: Animals; Dioxanes; Dogs; Humans; Platelet Aggregation Inhibitors; Rats; Receptors, Thromboxane; Structure-Activity Relationship; Thromboxane-A Synthase | 1995 |
Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
Topics: Aspirin; Biphenyl Compounds; Drug Interactions; Fatty Acids, Monounsaturated; Heptanoic Acids; Humans; Imidazoles; In Vitro Techniques; Male; Pentanoic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridines; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane-A Synthase | 1991 |